| scholarly article | Q13442814 |
| P50 | author | Christopher Kuhlmann | Q84583677 |
| P2093 | author name string | Opeolu Adeoye | |
| Joseph Caruso | |||
| Phanichand Kodali | |||
| Julio Landero | |||
| Agnese Jurkevica | |||
| P2860 | cites work | Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts | Q22253182 |
| Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry | Q28204798 | ||
| Shotgun proteomics: tools for the analysis of complex biological systems | Q28215896 | ||
| Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome | Q31137938 | ||
| Characterization of the low molecular weight human serum proteome | Q31153810 | ||
| Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis | Q33515477 | ||
| National US Estimates of Recombinant Tissue Plasminogen Activator Use | Q61870350 | ||
| Comparative study of Zorbax Bio Series GF 250 and GF 450 and TSK-Gel 3000 SW and SWXL columns in size-exclusion chromatography of proteins | Q69041952 | ||
| Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers | Q81522770 | ||
| Probing the metal-homeostatis effects of the administration of chromium(vi) to mice by ICP MS and size-exclusion chromatography-ICP MS. | Q33745287 | ||
| Genomic organization of a new candidate tumor suppressor gene, LRP1B. | Q33921398 | ||
| Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years | Q33966207 | ||
| Gene expression profiling of blood for the prediction of ischemic stroke | Q34330510 | ||
| Blood biomarkers in cardioembolic stroke. | Q34362880 | ||
| The role of separation science in proteomics research | Q34431862 | ||
| Shotgun proteomics and biomarker discovery. | Q34938830 | ||
| Shotgun proteomics: integrating technologies to answer biological questions. | Q35180704 | ||
| Transient ischemic attacks characterized by RNA profiles in blood | Q35529958 | ||
| Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. | Q35751067 | ||
| Candidate-based proteomics in the search for biomarkers of cardiovascular disease | Q35990040 | ||
| Proteomic profiling of pancreatic cancer for biomarker discovery | Q36026306 | ||
| The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. | Q36209996 | ||
| Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition | Q36304858 | ||
| Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics | Q36370848 | ||
| Protein biomarker discovery and validation: the long and uncertain path to clinical utility | Q36561644 | ||
| Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm | Q36681471 | ||
| Increasing proteome coverage with offline RP HPLC coupled to online RP nanoLC-MS. | Q36990748 | ||
| A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: Application to the analysis of obesity, diabetes, and hypertension diseases | Q37096718 | ||
| Blood biomarkers in the diagnosis of ischemic stroke: a systematic review | Q37227913 | ||
| Blood markers for the prognosis of ischemic stroke: a systematic review | Q37415033 | ||
| Classification of stroke subtypes | Q37431215 | ||
| High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine | Q37455971 | ||
| Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment | Q37635613 | ||
| Multidimensional chromatography coupled to mass spectrometry in analysing complex proteomics samples. | Q37756771 | ||
| Regulation of endothelin-converting enzyme-1 expression in human neuroblastoma cells | Q40272486 | ||
| Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry | Q42621306 | ||
| Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. | Q43529232 | ||
| Increased plasma endothelin-1 in acute ischemic stroke | Q45114688 | ||
| Plasma biomarkers in the diagnosis of acute ischemic stroke | Q45330979 | ||
| Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap. | Q46012745 | ||
| Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites | Q46972135 | ||
| Size-exclusion chromatography in multidimensional separation schemes for proteome analysis | Q47449192 | ||
| Early Biomarkers of Stroke | Q48193653 | ||
| Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain | Q48488257 | ||
| Role of IL-1 in poststroke depressive-like behavior in mice | Q48520668 | ||
| Executive Summary: Heart Disease and Stroke Statistics—2010 Update | Q57413935 | ||
| Head-to-Head Comparison of Serum Fractionation Techniques | Q58068945 | ||
| P433 | issue | 17 | |
| P921 | main subject | ion trap | Q202012 |
| biomarker | Q864574 | ||
| P304 | page(s) | 2153-2161 | |
| P577 | publication date | 2012-07-16 | |
| P1433 | published in | Journal of Separation Science | Q15761632 |
| P1476 | title | Multiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: A pilot study | |
| P478 | volume | 35 |
| Q36539414 | A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection |
| Q58114606 | Mass spectrometry based translational neuroinjury proteomics |
| Q52846090 | Novel control modes to improve the performance of rectilinear ion trap mass spectrometer with dual pressure chambers. |
Search more.